A diagnostic scale for Alzheimer’s disease based on cerebrospinal fluid biomarker profiles
Main Authors: | Lehmann, Sylvain, Dumurgier, Julien, Schraen, Susanna, Wallon, David, Blanc, Frédéric, Magnin, Eloi, Bombois, Stéphanie, Bousiges, Olivier, Campion, Dominique, Cretin, Benjamin, Delaby, Constance, Hannequin, Didier, Jung, Barbara, Hugon, Jacques, Laplanche, Jean-Louis, Miguet-Alfonsi, Carole, Peoc’h, Katell, Philippi, Nathalie, Quillard-Muraine, Muriel, Sablonnière, Bernard, Touchon, Jacques, Vercruysse, Olivier, Paquet, Claire, Pasquier, Florence, Gabelle, Audrey |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255520/ |
Similar Items
-
Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study
by: Dumurgier, Julien, et al.
Published: (2015) -
Utility of CSF biomarkers in psychiatric disorders: a national multicentre prospective study
by: Paquet, Claire, et al.
Published: (2016) -
New highly sensitive rodent and human tests for soluble amyloid precursor protein alpha quantification: preclinical and clinical applications in Alzheimer’s disease
by: Rose, Christiane, et al.
Published: (2012) -
Genotyping Test with Clinical Factors: Better Management of Acute Postoperative Pain?
by: Hajj, Aline, et al.
Published: (2015) -
Cerebrospinal Fluid PKR Level Predicts Cognitive Decline in Alzheimer’s Disease
by: Dumurgier, Julien, et al.
Published: (2013)